Literature DB >> 8969211

Sialomucin complex, a heterodimeric glycoprotein complex. Expression as a soluble, secretable form in lactating mammary gland and colon.

E A Rossi1, R R McNeer, S A Price-Schiavi, J M Van den Brande, M Komatsu, J F Thompson, C A Carraway, N L Fregien, K L Carraway.   

Abstract

Ascites 13762 rat mammary adenocarcinoma cells express abundantly on their cell surfaces a heterodimeric glycoprotein complex composed of a sialomucin ascites sialoglycoprotein (ASGP)-1 and a transmembrane subunit ASGP-2. The latter, which contains two epidermal growth factor-like domains, binds the receptor tyrosine kinase p185(neu), suggesting that the complex is bifunctional as well as heterodimeric. Immunoblot analyses using monoclonal antibodies prepared against the complex demonstrate high levels of expression in rat lactating mammary gland and colon. Immunolocalization studies with anti-ASGP-2 indicate that ASGP-2 is present in these two tissues in the apical regions of secretory epithelial cells. Both mammary gland and colon contain a soluble, secretable form of ASGP-2, which is not found in the ascites cells; milk and mammary gland also have the membrane form. Immunoblot analyses using a COOH-terminal-specific polyclonal antibody indicate that the soluble form of ASGP-2 is missing its COOH-terminal domains. Both the soluble and membrane forms of ASGP-2 are similar to the membrane-associated form from the 13762 adenocarcinoma with respect to Mr, antigenicity, and association with ASGP-1. The presence of ASGP-1 in milk suggests that it is a candidate for the uncharacterized high Mr milk mucin, MUCX. ASGP-2 expression is up-regulated in mammary gland during pregnancy, because it is undetectable in virgin and early pregnant rats but abundant in the gland from late pregnant and lactating animals. However, compared with the lactating mammary gland, the 13762 ascites cells overexpress ASGP-2 by more than 100-fold, which may contribute to their malignancy. These combined results indicate that sialomucin complex is a unique secreted product in the mammary gland and colon, whose behavior is different from that in the mammary ascites tumors, and which may play important roles in mammary and intestinal physiology.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8969211     DOI: 10.1074/jbc.271.52.33476

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  26 in total

1.  Complete sequence of the human mucin MUC4: a putative cell membrane-associated mucin.

Authors:  N Moniaux; S Nollet; N Porchet; P Degand; A Laine; J P Aubert
Journal:  Biochem J       Date:  1999-03-01       Impact factor: 3.857

2.  Mechanistic and signaling analysis of Muc4-ErbB2 signaling module: new insights into the mechanism of ligand-independent ErbB2 activity.

Authors:  Goldi A Kozloski; Coralie A Carothers Carraway; Kermit L Carraway
Journal:  J Cell Physiol       Date:  2010-09       Impact factor: 6.384

3.  MUC16 in the lacrimal apparatus.

Authors:  Kristin Jäger; Guangxi Wu; Saadettin Sel; Fabian Garreis; Lars Bräuer; Friedrich P Paulsen
Journal:  Histochem Cell Biol       Date:  2007-01-09       Impact factor: 4.304

4.  Muc4-ErbB2 complex formation and signaling in polarized CACO-2 epithelial cells indicate that Muc4 acts as an unorthodox ligand for ErbB2.

Authors:  Victoria P Ramsauer; Vanessa Pino; Amjad Farooq; Coralie A Carothers Carraway; Pedro J I Salas; Kermit L Carraway
Journal:  Mol Biol Cell       Date:  2006-04-19       Impact factor: 4.138

5.  Sialomucin complex in the rat respiratory tract: a model for its role in epithelial protection.

Authors:  R R McNeer; D Huang; N L Fregien; K L Carraway
Journal:  Biochem J       Date:  1998-03-01       Impact factor: 3.857

6.  The membrane mucin Muc4 inhibits apoptosis induced by multiple insults via ErbB2-dependent and ErbB2-independent mechanisms.

Authors:  Heather C Workman; Colleen Sweeney; Kermit L Carraway
Journal:  Cancer Res       Date:  2009-03-17       Impact factor: 12.701

7.  Regulation of the membrane mucin Muc4 in corneal epithelial cells by proteosomal degradation and TGF-beta.

Authors:  Joseph Lomako; Wieslawa M Lomako; Coralie A Carothers Carraway; Kermit L Carraway
Journal:  J Cell Physiol       Date:  2010-04       Impact factor: 6.384

Review 8.  Review of the adenocarcinoma cell surface receptor for human alpha-fetoprotein; proposed identification of a widespread mucin as the tumor cell receptor.

Authors:  G J Mizejewski
Journal:  Tumour Biol       Date:  2013-02-28

9.  The membrane mucin MUC4 is elevated in breast tumor lymph node metastases relative to matched primary tumors and confers aggressive properties to breast cancer cells.

Authors:  Heather C Workman; Jamie K Miller; Ellen Q Ingalla; Rouminder P Kaur; Diane I Yamamoto; Laurel A Beckett; Lawrence Jt Young; Robert D Cardiff; Alexander D Borowsky; Kermit L Carraway; Colleen Sweeney; Kermit L Carraway
Journal:  Breast Cancer Res       Date:  2009       Impact factor: 6.466

10.  Mucin dynamics in intestinal bacterial infection.

Authors:  Sara K Lindén; Timothy H J Florin; Michael A McGuckin
Journal:  PLoS One       Date:  2008-12-17       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.